Clin2
NCT05641935Possibly a fitRecruiting

Ultrasound scan to check kidney cancer return after ablation

Recurrent Renal Cell CarcinomaRenal Cell Carcinoma

Treatments studied

Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tests whether a special ultrasound scan with contrast can help doctors find kidney cancer that comes back after a procedure called ablation. It may help improve monitoring by comparing the ultrasound results with CT or MRI scans done soon after treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
210 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have had cryotherapy or microwave treatment to treat kidney cancer (RCC) previously
  • You have CT or MRI scans with contrast available before your ablation treatment
  • You are getting (or already had) a contrast CT or MRI to check for cancer returning within 4 weeks of the ultrasound study
  • You are 18 years old or older
  • You are medically stable enough for study visits and testing
  • If you could become pregnant, you have a negative pregnancy test, and you can sign consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07346404Not yet recruiting· Phase 2
PET scan for grading kidney cancer

This study tests whether a special PET scan (using a radioactive tracer called rubidium-82) can help doctors better understand how aggressive a kidney cancer is before surgery. If you have a medium-sized kidney tumor that looks like clear cell cancer and you are scheduled for surgery, you may be able to join.

Paris
NCT06261814Recruiting· Phase 2
Ultrasound to check chemoembolization for liver tumors

This trial uses a special ultrasound with a contrast agent to see how well a liver cancer treatment called TACE is working. It may help doctors better understand if the treatment is shrinking the tumor.

Philadelphia, Pennsylvania
NCT07272083Not yet recruiting
New ways to check if liver cancer ablation worked

This study tests new criteria for evaluating how well thermal ablation (using heat to destroy cancer nodules) worked in people with hepatocellular carcinoma (HCC, a type of liver cancer). It aims to improve follow-up imaging with contrast-enhanced ultrasound (CEUS) or CT/MRI to see if the treatment was successful.

Roma
NCT06447103Recruiting· Phase 2
New scan to find kidney cancer after surgery

This trial tests a special PET scan to see if it can better find leftover kidney cancer after surgery compared to a standard CT scan. You may qualify if you had kidney cancer surgery within the last 4-16 weeks and are at high risk of the cancer coming back.

Los Angeles, California
NCT07077083Not yet recruiting· Phase 2
PET scan for kidney cancer after treatment

This trial uses a special PET scan to detect if kidney cancer remains or returns after treatment. It may help find cancer that's hard to see on other scans.

Boston, Massachusetts
NCT07600346Not yet recruiting
Ultrasound imaging methods for detecting cancer return after liver surgery

This study compares two different ultrasound imaging techniques to see which one is better at detecting whether liver cancer has come back after surgery. If you've had liver cancer surgery and now have a new spot on your liver, this trial may help doctors diagnose it more accurately.

Hear when a new Renal Cell Carcinoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.